U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. UT Southwestern discusses what we know about the risks, as well as ongoing research to reveal more answers.
Acute rejection of a lung transplant is surprisingly normal; 40 to 50 percent of transplant patients deal with it during the first year after surgery. Discover why UT Southwestern says these rejections are very treatable through medication at home or at the doctor’s office.
How can a microscopic respiratory infection such as COVID-19 wreak such havoc in the body so quickly? And why do some patients get hit harder than others. UT Southwestern discusses how a coronavirus can progress in our respiratory tracts.
Data released in April 2018 suggest that adding immunotherapy to chemotherapy can extend the lives of some advanced lung cancer patients. Discover how immunotherapy works and who might benefit.